Home/Filings/4/0001415889-18-000539
4//SEC Filing

MAFFUID PAUL W 4

Accession 0001415889-18-000539

CIK 0001109196other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 6:25 PM ET

Size

9.2 KB

Accession

0001415889-18-000539

Insider Transaction Report

Form 4
Period: 2018-04-02
Transactions
  • Exercise/Conversion

    Common Stock

    2018-04-02+5,015101,612 total
  • Exercise/Conversion

    Restricted Stock Unit

    2018-04-025,0150 total
    Common Stock (5,015 underlying)
  • Tax Payment

    Common Stock

    2018-04-021,73599,877 total
Footnotes (4)
  • [F1]Represents conversion of restricted stock units into common stock upon vesting of 1/3 of such units granted on April 2, 2015.
  • [F2]Represents withholding by the Issuer of shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the above conversion of restricted stock units into common stock.
  • [F3]Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer.
  • [F4]Restricted Stock Units vest over 3 years from April 2, 2015, 1/3 on each anniversary of the date of grant, subject to the Reporting Person's continued employment or service with the Issuer on each such vesting date

Issuer

MABVAX THERAPEUTICS HOLDINGS, INC.

CIK 0001109196

Entity typeother

Related Parties

1
  • filerCIK 0001170363

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 6:25 PM ET
Size
9.2 KB